Cerebral microbleeds: A review of clinical, genetic, and neuroimaging associations

Frontiers in Neurology

Volumn 4 JAN, Issue , 2014, Pages

  Yates, Paul A ^a,b   Villemagne, Victor L ^a,b   Ellis, Kathryn A ^b   Desmond, Patricia M ^b,c   Masters, Colin L ^b   Rowe, Christopher C ^a,b  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; Amyloid imaging; Cerebral amyloid angiopathy; Intracerebral hemorrhage; Microbleeds; MRI imaging; Positron emission tomography; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; APOE GENE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DNA POLYMORPHISM; GENETIC ASSOCIATION; HUMAN; LACUNAR STROKE; MORTALITY; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SUSCEPTIBILITY WEIGHTED IMAGING; T2 GRADIENT RECALL ECHO; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

EID: 84893456095     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00205     Document Type: Review

References (181)

1. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology (1998) 51:690-4. doi: 10.1212/WNL.51.3.690.
2. Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, et al. Long-term mortality after intracerebral hemorrhage. Neurology (2006) 66:1182-6. doi:10.1212/01.wnl.0000208400.08722.7c.
3. Qureshi AI, Suri MFK, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke (2002) 33:2781-8. doi:10.1161/01.STR.0000039402.05613.0F.
4. Kurth T, Kase CS, Berger K, Gaziano JM, Cook NR, Buring JE. Smoking and risk of hemorrhagic stroke in women. Stroke (2003) 34:2792-5. doi:10.1161/01.STR.0000065200.93070.32.
5. Matsukawa H, Shinoda M, Fujii M, Takahashi O, Yamamoto D, Murakata A, et al. Factors associated with lobar vs. non-lobar intracerebral hemorrhage. Acta Neurol Scand (2011) [cited 2012 Feb 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22067041.
6. Hillbom M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep (2011) 13:208-13. doi:10.1007/s11906-011-0194-y.
7. Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 34:2060-5. doi:10.1161/01.STR.0000080678.09344.8D.
8. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 9:689-701. doi:10.1016/S1474-4422(10)70104-6.
9. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 19:547-54. doi:10.1161/01.STR.19.5.547.
10. Jeon S-B, Kang D-W, Cho A-H, Lee E-M, Choi CG, Kwon SU, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol (2007) 254:508-12. doi:10.1007/s00415-006-0406-6.
11. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 35:1415-20. doi:10.1161/01.STR.0000126807.69758.0e.
12. Gao T, Wang Y, Zhang Z. Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurol Res (2008) 30:272-6. doi:10.1179/016164107X251556.
13. Pettersen JA, Sathiyamoorthy G, Gao F-Q, Szilagyi G, Nadkarni NK, St George-Hyslop P, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol (2008) 65:790-5. doi:10.1001/archneur.65.6.790.
14. Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 9:363-72. doi:10.1016/S1474-4422(10)70043-0.
15. Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 7:367-85. doi:10.1016/j.jalz.2011.05.2351.
16. Poels MMF, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke (2010) 41:S103-6. doi:10.1161/STROKEAHA.110.595181.
17. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, Kjartansson O, Eiriksdottir G, Valtysdottir B, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 79:1002-6. doi:10.1136/jnnp.2007.121913.
18. Blitstein MK, Tung GA. MRI of cerebral microhemorrhages. AJR Am J Roentgenol (2007) 189:720-5. doi:10.2214/AJR.07.2249.
19. Dichgans M, Holtmannspötter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL. Stroke (2002) 33:67-71. doi:10.1161/hs0102.100885.
20. Roob G, Fazekas F. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol (2000) 13:69-73. doi:10.1097/00019052-200002000-00013.
21. Kwa VI, Franke CL, Verbeeten B Jr, Stam J. Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group. Ann Neurol (1998) 44:372-7.
22. Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke (2002) 33:1536-40. doi:10.1161/01.STR.0000018012.65108.86.
23. Takashima Y, Mori T, Hashimoto M, Kinukawa N, Uchino A, Yuzuriha T, et al. Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds. J Stroke Cerebrovasc Dis (2011) 20:105-10. doi:10.1016/j.jstrokecerebrovasdis.2009.11.007.
24. Werring DJ, Gregoire SM, Cipolotti L. Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci (2010) 299:131-5. doi:10.1016/j.jns.2010.08.034.
25. Nishikawa T, Ueba T, Kajiwara M, Fujisawa I, Miyamatsu N, Yamashita K. Cerebral microbleeds predict first-ever symptomatic cerebrovascular events. Clin Neurol Neurosurg (2009) 111:825-8. doi:10.1016/j.clineuro.2009.08.011.
26. Senior K. Microbleeds may predict cerebral bleeding after stroke. Lancet (2002) 359:769. doi:10.1016/S0140-6736(02)07911-4.
27. Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology (1988) 168:803-7.
28. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with magnetic resonance imaging using susceptibility-weighted imaging: a case study. J Magn Reson Imaging (2009) 29:177-82. doi:10.1002/jmri.21617.
29. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke (1999) 30:1637-42. doi:10.1161/01.STR.30.8.1637.
30. Vernooij MW, Ikram MA, Hofman A, Krestin GP, Breteler MMB, van der Lugt A. Superficial siderosis in the general population. Neurology (2009) 73:202-5. doi:10.1212/WNL.0b013e3181ae7c5e.
31. De Reuck J, Deramecourt V, Cordonnier C, Leys D, Pasquier F, Maurage C-A. Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study. J Neurol Sci (2011) 300:63-6. doi:10.1016/j.jns.2010.09.031.
32. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol (1999) 20:637-42.
33. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 32:528-34. doi:10.1159/000331466.
34. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 70:1208-14. doi:10.1212/01.wnl.0000307750.41970.d9.
35. Kim M, Bae HJ, Lee J, Kang L, Lee S, Kim S, et al. APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI. Neurology (2005) 65:1474-5. doi:10.1212/01.wnl.0000183311.48144.7f.
36. Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology (2011) 77:48-54. doi:10.1212/WNL.0b013e318221ad36.
37. Imaizumi T, Miyata K, Inamura S, Kohama I, Nyon KS, Nomura T. The difference in location between traumatic cerebral microbleeds and microangiopathic microbleeds associated with stroke. J Neuroimaging (2011) 21:359-64. doi:10.1111/j.1552-6569.2011.00593.x.
38. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci (1993) 116:135-41. doi:10.1016/0022-510X(93)90317-R.
39. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 56:537-539. doi:10.1212/WNL.56.4.537.
40. van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, et al. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 40:3022-7. doi:10.1161/STROKEAHA.109.554378.
41. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 74:1346-50. doi:10.1212/WNL.0b013e3181dad605.
42. Von sattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 30:637-649. doi:10.1002/ana.410300503.
43. Rosand J, Muzikansky A, Kumar A, Wisco JJ, Smith EE, Betensky RA, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 58:459-62. doi:10.1002/ana.20596.
44. Vinters H, Gilbert J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1983) 14:924-8. doi:10.1161/01.STR.14.6.924.
45. Won Seo S, Hwa Lee B, Kim E-J, Chin J, Sun Cho Y, Yoon U, et al. Clinical significance of microbleeds in subcortical vascular dementia. Stroke (2007) 38:1949-51. doi:10.1161/STROKEAHA.106.477315.
46. Chalmers K, Wilcock GK, Love S. APOEe4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Abeta protein. Neuropathol Appl Neurobiol (2003) 29:231-8. doi:10.1046/j.1365-2990.2003.00457.x.
47. Sullivan PM, Mace BE, Estrada JC, Schmechel DE, Alberts MJ. Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. J Stroke Cerebrovasc Dis (2008) 17:303-11. doi:10.1016/j.jstrokecerebrovasdis.2008.03.011.
48. Trembath D, Ervin JF, Broom L, Szymanski M, Welsh-Bohmer K, Pieper C, et al. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. Acta Neuropathol (2006) 113:23-31. doi:10.1007/s00401-006-0162-9.
49. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 58:711-8. doi:10.1097/00005072-199907000-00005.
50. Maxwell SS, Jackson CA, Paternoster L, Cordonnier C, Thijs V, Al-Shahi Salman R, et al. Genetic associations with brain microbleeds: systematic review and meta-analyses. Neurology (2011) 77:158-67. doi:10.1212/WNL.0b013e318224afa3.
51. Yamada M. Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci (2004) 226:41-4. doi:10.1016/j.jns.2004.09.009.
52. Biffi A, Shulman JM, Jagiella JM, Cortellini L, Ayres AM, Schwab K, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 78:334-41. doi:10.1212/WNL.0b013e3182452b40.
53. Joutel A, Bousser M-G, Biousse V, Labauge P, Chabriat H, Nibbio A, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet (1993) 5:40-5. doi:10.1038/ng0993-40.
54. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (1990) 248:1124-6. doi:10.1126/science.2111584.
55. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 49:697-705. doi:10.1002/ana.1009.
56. Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, et al. Cerebral microbleeds in familial Alzheimer's disease. Brain (2012) 135(1):e201. doi:10.1093/brain/awr126.
57. Saint-Aubert L, Planton M, Hannequin D, Albucher J-F, Delisle M-B, Payoux P, et al. Amyloid imaging with AV45 (18F-florbetapir) in a cognitively normal AβPP duplication carrier. J Alzheimers Dis (2012) 28:877-83. doi:10.3233/JAD-2011-111598.
58. Liu T, Surapaneni K, Lou M, Cheng L, Spincemaille P, Wang Y. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology (2012) 262:269-78. doi:10.1148/radiol.11110251.
59. Nandigam RNK, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2009) 30:338-43. doi:10.3174/ajnr.A1355.
60. Stehling C, Wersching H, Kloska SP, Kirchhof P, Ring J, Nassenstein I, et al. Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol (2008) 15:895-900. doi:10.1016/j.acra.2008.01.013.
61. Tatsumi S, Ayaki T, Shinohara M, Yamamoto T. Type of gradient recalled-echo sequence results in size and number change of cerebral microbleeds. AJNR Am J Neuroradiol (2008) 29:e13-13. doi:10.3174/ajnr.A0908.
62. Conijn MMA, Hoogduin JM, van der Graaf Y, Hendrikse J, Luijten PR, Geerlings MI. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity-a 7 T study. Neuroimage (2012) 59:950-6. doi:10.1016/j.neuroimage.2011.08.059.
63. De Reuck J, Caparros-Lefebvre D, Deramecourt V, Maurage CA. Hippocampal microbleed on a post-mortem t(2)*-weighted gradient-echo 7.0-tesla magnetic resonance imaging? Case Rep Neurol (2011) 3:223-6. doi:10.1159/000332611.
64. Goos JDC, van der Flier WM, Knol DL, Pouwels PJW, Scheltens P, Barkhof F, et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke (2011) 42:1894-900. doi:10.1161/STROKEAHA.110.599837.
65. Akiyama Y, Miyata K, Harada K, Minamida Y, Nonaka T, Koyanagi I, et al. Susceptibility-weighted magnetic resonance imaging for the detection of cerebral microhemorrhage in patients with traumatic brain injury. Neurol Med Chir (Tokyo) (2009) 49:97-9. doi:10.2176/nmc.49.97 discussion 99,.
66. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CLM, et al. Improving interrater agreement about brain microbleeds. Stroke (2009) 40:94-9. doi:10.1161/STROKEAHA.108.526996.
67. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology (2009) 73:1759-66. doi:10.1212/WNL.0b013e3181c34a7d.
68. Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 31:142-8. doi:10.1002/jmri.22001.
69. Lee S-H, Lee S-T, Kim BJ, Park H-K, Kim C-K, Jung K-H, et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS One (2011) 6:e25930. doi:10.1371/journal.pone.0025930.
70. Poels MMF, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MMB, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke (2011) 42:656-61. doi:10.1161/STROKEAHA.110.607184.
71. Asif IM, Harmon KG, Drezner JA, O'Kane JW. Cerebral microhemorrhages in a collegiate football player. Sports Health (2010) 2(5):391-4. doi:10.1177/1941738110374628.
72. Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis (2009) 17:599-609. doi:10.3233/JAD-2009-1073.
73. Fazlollahi A, Meriaudau F, Giancardo L, Desmond PM, Villemagne VL, Rowe CC, et al. Automatic detection of cerebral microbleed in SWI using radon transform. Proceedings of ISMRM 2013 (2013).
74. Seghier ML, Kolanko MA, Leff AP, Jäger HR, Gregoire SM, Werring DJ. Microbleed detection using automated segmentation (MIDAS): a new method applicable to standard clinical MR images. PLoS One (2011) 6:e17547. doi:10.1371/journal.pone.0017547.
75. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol (2003) 24:88-96.
76. Yakushiji Y, Yokota C, Yamada N, Kuroda Y, Minematsu K. Clinical characteristics by topographical distribution of brain microbleeds, with a particular emphasis on diffuse microbleeds. J Stroke Cerebrovasc Dis (2010) [cited 2011 Feb 1]. doi:10.1016/j.jstrokecerebrovasdis.2009.12.001 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20621512.
77. Alemany M, Stenborg A, Terent A, Sonninen P, Raininko R. Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data. Radiology (2006) 238:240-7. doi:10.1148/radiol.2381040551.
78. Nakata-Kudo Y, Mizuno T, Yamada K, Shiga K, Yoshikawa K, Mori S, et al. Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord (2006) 22:8-14. doi:10.1159/000092958.
79. Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Abe K. Cerebral microbleeds in Alzheimer's disease. J Neurol (2003) 250:1496-7. doi:10.1007/s00415-003-0245-7.
80. Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Fujita H, Kaneko N, et al. Cerebral microbleeds in Binswanger's disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett (2003) 340:213-6. doi:10.1016/S0304-3940(03)00121-6.
81. Zhu Y-C, Chabriat H, Godin O, Dufouil C, Rosand J, Greenberg SM, et al. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol (2011) [cited 2011 Dec 5]. doi:10.1007/s00415-011-6218-3 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21877206.
82. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease. Stroke (2008) 39:1127-33. doi:10.1161/STROKEAHA.107.497438.
83. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke (1997) 28:652-9. doi:10.1161/01.STR.28.3.652.
84. Gouw A, Seewann A, van der Flier W, Barkhof F, Rozemuller A, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2011) 82:126-35. doi:10.1136/jnnp.2009.204685.
85. Chowdhury MH, Nagai A, Bokura H, Nakamura E, Kobayashi S, Yamaguchi S. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J Stroke Cerebrovasc Dis (2011) 20:302-9. doi:10.1016/j.jstrokecerebrovasdis.2009.12.010.
86. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 80:1551-6. doi:10.1212/WNL.0b013e31828f1876.
87. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 55:306-19. doi:10.1002/ana.20009.
88. Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain (2007) 130:2607-15. doi:10.1093/brain/awm191.
89. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 131:1630-45. doi:10.1093/brain/awn016.
90. Greenberg SM, Grabowski T, Gurol ME, Skehan ME, Nandigam RNK, Becker JA, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 64:587-91. doi:10.1002/ana.21528.
91. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 62:229-34. doi:10.1002/ana.21164.
92. Ly JV, Donnan GA, Villemagne VL, Zavala JA, Ma H, O'Keefe G, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology (2010) 74:487-93. doi:10.1212/WNL.0b013e3181cef7e3.
93. Dierksen GA, Skehan ME, Khan MA, Jeng J, Nandigam RNK, Becker JA, et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 68:545-8. doi:10.1002/ana.22099.
94. Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin A, Becker A, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 79:320-6. doi:10.1212/WNL.0b013e31826043a9.
95. Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, et al. Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimers Dement (2013) [cited 2013 Feb 28]. Available from: http://www.sciencedirect.com/science/article/pii/S1552526012025733.
96. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2012). doi:10.1002/ana.23830.
97. Han BH, Zhou M, Vellimana AK, Milner E, Kim DH, Greenberg JK, et al. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy. Mol Neurodegener (2011) 6:86. doi:10.1186/1750-1326-6-86.
98. Zha Z, Choi SR, Ploessl K, Lieberman BP, Qu W, Hefti F, et al. Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). J Med Chem (2011) 54:8085-98. doi:10.1021/jm2009106.
99. Verbeek MM, Kremer BPH, Rikkert MO, Van Domburg PHMF, Skehan ME, Greenberg SM. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol (2009) 66:245-9. doi:10.1002/ana.21694.
100. Goos JDC, Teunissen CE, Veerhuis R, Verwey NA, Barkhof F, Blankenstein MA, et al. Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease. Neurobiol Aging (2012) 33:.e1-1011. doi:10.1016/j.neurobiolaging.2011.10.026.
101. Orken DN, Kenangil G, Uysal E, Gundogdu L, Erginoz E, Forta H. Lack of association between cerebral microbleeds and low serum cholesterol in patients with acute intracerebral hemorrhage. Clin Neurol Neurosurg (2010) 112:668-71. doi:10.1016/j.clineuro.2010.05.004.
102. Fiehler J, Albers GW, Boulanger J-M, Derex L, Gass A, Hjort N, et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 38:2738-44. doi:10.1161/STROKEAHA.106.480848.
103. Tang WK, Chen YK, Lu JY, Mok VCT, Xiang YT, Ungvari GS, et al. Microbleeds and post-stroke emotional lability. J Neurol Neurosurg Psychiatry (2009) 80:1082-6. doi:10.1136/jnnp.2009.175372.
104. Fan YH, Zhang L, Lam WWM, Mok VCT, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke (2003) 34:2459-62. doi:10.1161/01.STR.0000090841.90286.81.
105. Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke (2000) 31:2665-9. doi:10.1161/01.STR.31.11.2665.
106. Yamada SS. Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age. Eur J Neurol (2012) 19:98-104. doi:10.1111/j.1468-1331.2011.03451.x.
107. Schonewille WJ, Singer MB, Atlas SW, Tuhrim S. The prevalence of microhemorrhage on gradient-echo magnetic resonance imaging in acute lacunar infarction. J Stroke Cerebrovasc Dis (2005) 14:141-4. doi:10.1016/j.jstrokecerebrovasdis.2005.05.003.
108. Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology (2010) [cited 2012 Feb 17]. doi:10.1148/radiol.10100612 Available from: http://radiology.rsna.org.ezp.lib.unimelb.edu.au/content/early/2010/08/31/radiol.10100612.abstract.
109. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 66:1356-60. doi:10.1212/01.wnl.0000210535.20297.ae.
110. van den Boom R, Lesnik Oberstein SAJ, Ferrari MD, Haan J, van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages-3rd-6th decades. Radiology (2003) 229:683-90. doi:10.1148/radiol.2293021354.
111. Viswanathan A, Guichard J-P, Gschwendtner A, Buffon F, Cumurcuic R, Boutron C, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain (2006) 129:2375-83. doi:10.1093/brain/awl177.
112. Kapina V, Vargas M-I, Vulliemoz S, Landis T, Picard F, Lalive PH. VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophy. J Neurol (2009) 257:466-8. doi:10.1007/s00415-009-5370-5.
113. Hasiloglu ZI, Albayram S, Selcuk H, Ceyhan E, Delil S, Arkan B, et al. Cerebral microhemorrhages detected by susceptibility-weighted imaging in amateur boxers. AJNR Am J Neuroradiol (2011) 32:99-102. doi:10.3174/ajnr.A2250.
114. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 67:83-7. doi:10.1212/01.wnl.0000223613.57229.24.
115. Goos JDC, Henneman WJP, Sluimer JD, Vrenken H, Sluimer IC, Barkhof F, et al. Incidence of cerebral microbleeds. Neurology (2010) 74:1954-1960. doi:10.1212/WNL.0b013e3181e396ea.
116. Gregoire SM, Brown MM, Kallis C, Jäger HR, Yousry TA, Werring DJ. MRI detection of new microbleeds in patients with ischemic stroke five-year cohort follow-up study. Stroke (2010) 41:184-6. doi:10.1161/STROKEAHA.109.568469.
117. Greenberg SM, O'Donnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology (1999) 53:1135-1135. doi:10.1212/WNL.53.5.1135.
118. Jia Z, Mohammed W, Qiu Y, Hong X, Shi H. Hypertension increases the risk of cerebral microbleed in the territory of posterior cerebral artery: a study of the association of microbleeds categorized on a basis of vascular territories and cardiovascular risk factors. J Stroke Cerebrovasc Dis (2013). doi:10.1016/j.jstrokecerebrovasdis.2012.12.016.
119. Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke (2012) 43:2916-22. doi:10.1161/STROKEAHA.112.658369.
120. Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, et al. A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 24:198-203. doi:10.1097/WAD.0b013e3181c53b00.
121. Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 73:2061-70. doi:10.1212/WNL.0b013e3181c67808.
122. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 6:916-9. doi:10.1038/78682.
123. Daniëls R, Geurts JJG, Bot JC, Schonewille WJ, van Oosten BW. Steroid-responsive edema in CAA-related inflammation. J Neurol (2009) 256:285-6. doi:10.1007/s00415-009-0136-7.
124. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 55:250-6. doi:10.1002/ana.10810.
125. Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation (2004) 1:24. doi:10.1186/1742-2094-1-24.
126. Wilcock DM, Jantzen PT, Li Q, Morgan D, Gordon MN. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid. Neuroscience (2007) 144:950-60. doi:10.1016/j.neuroscience.2006.10.020.
127. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med (2012) 4:147ra111. doi:10.1126/scitranslmed.3003748.
128. Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol (2012) 69:198-207. doi:10.1001/archneurol.2011.1538.
129. Sperling RA, Bronen R, Greenberg S, Sorensen G, Salloway S, Gass A. Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD. Alzheimers Dement (2011) 7(4):S377. doi:10.1016/j.jalz.2011.05.1085.
130. Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, et al. Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab. Alzheimers Dement (2011) 7:396-401. doi:10.1016/j.jalz.2011.05.2353.
131. Rosidi NL, Zhou J, Pattanaik S, Wang P, Jin W, Brophy M, et al. Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration. PLoS One (2011) 6:e26612. doi:10.1371/journal.pone.0026612.
132. van Norden AGW, van den Berg HAC, de Laat KF, Gons RAR, van Dijk EJ, de Leeuw F-E. Frontal and temporal microbleeds are related to cognitive function: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study. Stroke (2011) 42:3382-6. doi:10.1161/STROKEAHA.111.629634.
133. Patel B, Lawrence AJ, Chung AW, Rich P, Mackinnon AD, Morris RG, et al. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke (2013) 44:356-61. doi:10.1161/STROKEAHA.112.670216.
134. Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, et al. Cerebral microbleeds, retinopathy, and dementia. Neurology (2010) 75:2221-2228. doi:10.1212/WNL.0b013e3182020349.
135. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain (2004) 127:2265-75. doi:10.1093/brain/awh253.
136. Poels MMF, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology (2012) 78:326-33. doi:10.1212/WNL.0b013e3182452928.
137. Gregoire SM, Scheffler G, Jäger HR, Yousry TA, Brown MM, Kallis C, et al. Strictly lobar microbleeds are associated with executive impairment in patients with ischemic stroke or transient ischemic attack. Stroke (2013) 44:1267-72. doi:10.1161/STROKEAHA.111.000245.
138. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2011) 69:320-7. doi:10.1002/ana.22112.
139. Tang WK, Chen Y-K, Lu J-Y, Wong A, Mok V, Chu WCW, et al. Absence of cerebral microbleeds predicts reversion of vascular "cognitive impairment no dementia" in stroke. Int J Stroke (2011) 6:498-505. doi:10.1111/j.1747-4949.2011.00682.x.
140. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex L, Honnorat J, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke. Stroke (2002) 33:735-42. doi:10.1161/hs0302.104615.
141. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham study. Stroke (2004) 35:1831-5. doi:10.1161/01.STR.0000131809.35202.1b.
142. Altmann-Schneider I, Trompet S, de Craen AJM, van Es ACGM, Jukema JW, Stott DJ, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke (2011). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21233474.
143. Tsushima Y, Tanizaki Y, Aoki J, Endo K. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology (2002) 44:31-6. doi:10.1007/s002340100649.
144. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 130:1988-2003. doi:10.1093/brain/awl387.
145. Vergouwen MDI, de Haan RJ, Vermeulen M, Roos YBWEM. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke (2008) 39:497-502. doi:10.1161/STROKEAHA.107.488791.
146. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 8:453-63. doi:10.1016/S1474-4422(09)70058-4.
147. Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, et al. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 124:2233-42. doi:10.1161/CIRCULATIONAHA.111.055269.
148. Bokura H, Saika R, Yamaguchi T, Nagai A, Oguro H, Kobayashi S, et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke (2011) 42:1867-71. doi:10.1161/STROKEAHA.110.601922.
149. Jeong S-W, Jung K-H, Chu K, Bae H-J, Lee S-H, Roh J-K. Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images. Arch Neurol (2004) 61:905-9. doi:10.1001/archneur.61.6.905.
150. Greenberg SM, Nandigam RNK, Delgado P, Betensky RA, Rosand J, Viswanathan A, et al. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 40:2382-6. doi:10.1161/STROKEAHA.109.548974.
151. Boulanger J-M, Coutts SB, Eliasziw M, Gagnon AJ, Simon JE, Subramaniam S, et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke (2006) 37:911-4. doi:10.1161/01.STR.0000204237.66466.5f.
152. Imaizumi T, Horita Y, Hashimoto Y, Niwa J. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg (2004) 101:915-20. doi:10.3171/jns.2004.101.6.0915.
153. Thijs V, Lemmens R, Schoofs C, Görner A, Van Damme P, Schrooten M, et al. Microbleeds and the risk of recurrent stroke. Stroke (2010) 41:2005-9. doi:10.1161/STROKEAHA.110.588020.
154. Huang P, Chen C-H, Lin W-C, Lin R-T, Khor G-T, Liu C-K. Clinical applications of susceptibility weighted imaging in patients with major stroke. J Neurol (2011) [cited 2012 Feb 7]. doi:10.1007/s00415-011-6369-2 Available at: http://www.ncbi.nlm.nih.gov/pubmed/22186853.
155. Soo YOY, Yang SR, Lam WWM, Wong A, Fan YH, Leung HHW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 255:1679-86. doi:10.1007/s00415-008-0967-7.
156. Sueda Y, Naka H, Ohtsuki T, Kono T, Aoki S, Ohshita T, et al. Positional relationship between recurrent intracerebral hemorrhage/lacunar infarction and previously detected microbleeds. Am J Neuroradiol (2010) 31:1498-503. doi:10.3174/ajnr.A2100.
157. Arima H, Tzourio C, Anderson C, Woodward M, Bousser M-G, MacMahon S, et al. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke (2010) 41:394-6. doi:10.1161/STROKEAHA.109.563932.
158. Gregoire SM, Jäger HR, Yousry TA, Kallis C, Brown MM, Werring DJ. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry (2010) 81:679-84. doi:10.1136/jnnp.2009.198994.
159. Naka H, Nomura E, Kitamura J, Imamura E, Wakabayashi S, Matsumoto M. Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents. J Stroke Cerebrovasc Dis (2013) 22(6):834-40. doi:10.1016/j.jstrokecerebrovasdis.2012.06.001.
160. Wong KS, Mok V, Lam WWM, Kay R, Tang A, Chan YL, et al. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology (2000) 54:2298-301. doi:10.1212/WNL.54.12.2298.
161. Ge L, Niu G, Han X, Gao Y, Wu Q, Wu H, et al. Aspirin treatment increases the risk of cerebral microbleeds. Can J Neurol Sci (2011) 38:863-8.
162. Vernooij MW, Haag MDM, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2009) 66:714-20. doi:10.1001/archneurol.2009.42.
163. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol (2008) 7:494-9. doi:10.1016/S1474-4422(08)70094-2.
164. Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology (2010) 75:693-698. doi:10.1212/WNL.0b013e3181eee40f.
165. Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CLM, Sorimachi T, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke (2010) 41:1222-8. doi:10.1161/STROKEAHA.109.572594.
166. Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, et al. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J (2013) 7(4):S377. doi:10.1093/eurheartj/eht445.
167. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 127:2166-76. doi:10.1161/CIRCULATIONAHA.112.142158.
168. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 361:1139-51. doi:10.1056/NEJMoa0905561.
169. Siegal DM, Crowther MA. Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J (2013) 34:489-98. doi:10.1093/eurheartj/ehs408.
170. Charidimou A, Shakeshaft C, Werring DJ. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 3:133. doi:10.3389/fneur.2012.00133.
171. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 363:768-74. doi:10.1016/S0140-6736(04)15692-4.
172. Chalela JA, Kang D-W, Warach S. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging (2004) 14:54-7. doi:10.1177/1051228403258673.
173. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis. Stroke (2002) 33:95-8. doi:10.1161/hs0102.101792.
174. Shoamanesh A, Kwok CS, Lim PA, Benavente OR. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke (2012). doi:10.1111/j.1747-4949.2012.00869.x.
175. Smith K. Should cerebral microbleeds on magnetic resonance imaging contraindicate thrombolysis in patients with ischaemic stroke? A systematic review of the evidence. Radiography (2011) 17:254-9. doi:10.1016/j.radi.2011.04.003.
176. Seo W-K, Lee J-M, Park MH, Park KW, Lee DH. Cerebral microbleeds are independently associated with arterial stiffness in stroke patients. Cerebrovasc Dis (2008) 26(6):618-23. doi:10.1159/000166837.
177. Lee S-H, Park J-M, Kwon S-J, Kim H, Kim Y-H, Roh J-K, et al. Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology (2004) 63:16-21. doi:10.1212/01.WNL.0000132525.36804.A1.
178. de Laat KF, van den Berg HAC, van Norden AGW, Gons RAR, Olde Rikkert MGM, de Leeuw F-E. Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease. Stroke (2011) 42:494-7. doi:10.1161/STROKEAHA.110.596122.
179. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology (1993) 43:2073-9. doi:10.1212/WNL.43.10.2073.
180. Simonsen CZ, Nielsen E. Hypertensive microbleed as a transient ischemic attack mimic. Case Rep Neurol (2013) 5:31-3. doi:10.1159/000348400.
181. Watanabe A, Kobashi T. Lateral gaze disturbance due to cerebral microbleed in the medial lemniscus in the mid-pontine region: a case report. Neuroradiology (2005) 47:908-11. doi:10.1007/s00234-005-1441-1.